Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Glioblastoma × pembrolizumab × Clear all

Phase

Phase 2 17 Phase 1/2 12 Phase 1 7 Phase 3 2 Phase 4 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Parkinson Disease 4, Autosomal Dominant Lewy Body 3 Carcinoma, Non-Small-Cell Lung 2 Urinary Bladder Neoplasms 1 Ureteral Neoplasms 1 Thyroid Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Pancreatic Neoplasms 1 Non-Small Cell Lung Cancer Metastatic 1 Neoplasms 1 Melanoma 1 Glioblastoma 1

Interventions

Temozolomide 2 trametinib 1 pembrolizumab 1 dabrafenib 1 Restraint, Physical 1 Radiotherapy 1 Radiosurgery 1 Radiation 1 Outcome Assessment, Health Care 1 Observational Studies as Topic 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05235737 2023-08-31

PIRG

Medical University of Silesia

Phase 4 Recruiting

Parkinson Disease 4, Autosomal Dominant Lewy Body, Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡